Insider Profile
May, Charlotte Mary-Anne
$XRTX
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Mar 04, 2024
Most Recent Trade
0
Credibility
Score
50%
Hit Rate
-12.0%
Avg 90d Return
-12.0%
Median 90d Return
2
Evaluated Trades
+0.9%
Best Trade
-24.9%
Worst Trade
Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Mar 04, 2024 $XRTX
XORTX Therapeutics Inc.
— Comp. Grant Buy 3,333 — — 55
Nov 10, 2023 $XRTX
XORTX Therapeutics Inc.
— Corp. Event Sell 13,334 — — 55
Nov 10, 2023 $XRTX
XORTX Therapeutics Inc.
— Corp. Event Sell 4,445 — — 55
Nov 10, 2023 $XRTX
XORTX Therapeutics Inc.
— Corp. Event Sell 18,928 — — 55
Mar 19, 2023 $XRTX
XORTX Therapeutics Inc.
— Expiry Sell 8,517 — — 55
Jan 12, 2022 $XRTX
XORTX Therapeutics Inc.
— Comp. Grant Buy 5,000 — — 55
Sep 24, 2021 $XRTX
XORTX Therapeutics Inc.
— Corp. Event Sell 228,706 — — 55
Sep 24, 2021 $XRTX
XORTX Therapeutics Inc.
— Corp. Event Sell 91,483 — — 55
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.